Accellacare of Wilmington, LLC

Wilmington, North Carolina 28401

0 studies enrolling now · 5 studies all time

What they study most

Obese, Obesity, Obesity or Overweight, Overweight, Overweight With One Weight Related Comorbidity, Overweight or Obese, Type 2 Diabetes Mellitus, Type 2 Diabetes Mellitus (T2DM)

Studies at this site

• A Study Evaluating the Effect of Daily Oral RO7795081 in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity — Completed
• A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes — Running, not enrolling
• A Study of Enicepatide (CT-388) in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus — Running, not enrolling
• A Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7204239 in Combination With Tirzepatide in Participants With Obesity or Overweight With At Least One Weight-related Comorbidity — Running, not enrolling
• Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus — Running, not enrolling